http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108822149-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9a38a062781e4e44718aa12bb10a153b
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65616
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6561
filingDate 2018-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e5ba337cb446cc7ba9acb90414075ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e3e5dc864331ad85082b683c795d828
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_edc0b0c35984e82ab86da9c811af5905
publicationDate 2018-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-108822149-A
titleOfInvention A kind of preparation method of key intermediate of tenofovir alafenamide fumarate
abstract The present invention belongs to the field of medicine synthesis, and relates to a preparation method of a medicine intermediate, in particular to a preparation method of a key intermediate of tenofovir alafenamide fumarate. The present invention provides a new method for preparing tenofovir alafenamide fumarate key intermediate 2 with high diastereomer purity. The method has the advantages of short reaction time, few by-products, simple operation and high product quality Good quality, high reaction yield, more suitable for industrial production and other characteristics.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111484527-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111484528-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115651023-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110272455-A
priorityDate 2018-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015161781-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468150994
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163950153
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467445316
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465739804
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68589647
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409037463
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468155684
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465718282
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1140
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457191321

Total number of triples: 28.